Literature DB >> 28569364

Anti-thyroglobulin antibodies and risk of finding iodine avid metastases on post-radioactive iodine ablation scan in low-risk thyroid cancer patients.

P W Rosario1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28569364     DOI： 10.1007/s40618-017-0704-0

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  3 in total

1.  A low postoperative nonstimulated serum thyroglobulin level excludes the presence of persistent disease in low-risk papillary thyroid cancer patients: implication for radioiodine indication.

Authors:  Pedro W Rosario; Gabriela F Mourão; Thassio Leonardo Siman; Maria Regina Calsolari
Journal:  Clin Endocrinol (Oxf)       Date:  2014-12-29       Impact factor: 3.478

Review 2.  Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level.

Authors:  C Nascimento; I Borget; A Al Ghuzlan; D Deandreis; L Chami; J P Travagli; D Hartl; J Lumbroso; C Chougnet; L Lacroix; E Baudin; M Schlumberger; S Leboulleux
Journal:  Endocr Relat Cancer       Date:  2011-03-03       Impact factor: 5.678

3.  Anti-thyroglobulin antibodies do not significantly increase the risk of finding iodine avid metastases on post-radioactive iodine ablation scan in low-risk thyroid cancer patients.

Authors:  F Nabhan; K Porter; L Senter; M D Ringel
Journal:  J Endocrinol Invest       Date:  2017-05-16       Impact factor: 4.256
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.